Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial
Chia Jui Yen, Hsiao Hui Tsou, Ching Yun Hsieh, Chang Yao Chu, Chang Fang Chiu, Chih Cheng Chen, Chao Jung Tsao, Kuo Yang Tsai, Sen Tien Tsai, Jang Yang Chang, Kwang Yu Chang
研究成果: 雜誌貢獻 › 文章 › 同行評審
11
引文
斯高帕斯(Scopus)